FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.21 | FHIR Version n/a User: [n/a]

14216311000001104: Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)
\UK product\Virtual medicinal product\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)
\UK product\Virtual therapeutic moiety\Clindamycin\Product containing only clindamycin in oral dose form (medicinal product form)\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)
\UK product\Virtual therapeutic moiety\Clindamycin\Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule\Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)
\UK product\Trade family\Dalacin C\Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

50549901000001116 Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

50550001000001114 Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel Import - supplier (qualifier value)	false	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel import	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Is a	Product containing precisely clindamycin (as clindamycin hydrochloride) 150 milligram/1 each conventional release oral capsule	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Has active ingredient	Clindamycin hydrochloride	false	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Has manufactured dose form	Conventional release oral capsule	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Is a	Dalacin C	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Clindamycin	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Has specific active ingredient	Clindamycin hydrochloride	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Has dispensed dose form	Capsule	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Has basis of strength substance	Clindamycin	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc) 24 capsule	Is pack of	False	Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Inferred relationship	Existential restriction modifier
Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc) 24 capsule	Has AMP	True	Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
50549901000001116	Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
50550001000001114	Dalacin C 150mg capsules (Sigma Pharmaceuticals Plc)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module